-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DSbyOLRA037uev4CRqJe1/IAoYEENyF6S9UTwsIErhz5ddnv+B15rdoQ+rahDbSL ZlVb/lNrvXj+j7B6k283XA== 0000950123-10-010803.txt : 20100210 0000950123-10-010803.hdr.sgml : 20100210 20100210113417 ACCESSION NUMBER: 0000950123-10-010803 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100210 DATE AS OF CHANGE: 20100210 GROUP MEMBERS: CHARLES I. CLOUGH, JR. GROUP MEMBERS: CLOUGH CAPITAL PARTNERS LLC GROUP MEMBERS: ERIC A. BROCK GROUP MEMBERS: JAMES E. CANTY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPHERE MEDICAL INC CENTRAL INDEX KEY: 0000919015 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 043216867 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-48675 FILM NUMBER: 10586730 BUSINESS ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 BUSINESS PHONE: 7816817900 MAIL ADDRESS: STREET 1: 1050 HINGHAM STREET CITY: ROCKLAND STATE: MA ZIP: 02370 FORMER COMPANY: FORMER CONFORMED NAME: BIOSEPRA INC DATE OF NAME CHANGE: 19940215 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CLOUGH CAPITAL PARTNERS L P CENTRAL INDEX KEY: 0001276144 IRS NUMBER: 043486480 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: ONE POST OFFICE SQUARE STREET 2: 40TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 6172043400 MAIL ADDRESS: STREET 1: ONE POST OFFICE SQUARE STREET 2: 40TH FLOOR CITY: BOSTON STATE: MA ZIP: 02109 SC 13G/A 1 b79403asc13gza.htm BIOSPHERE MEDICAL, INC. sc13gza
 
 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 5)*
BIOSPHERE MEDICAL, INC.
 
(Name of Issuer)
Common Stock
 
(Title of Class of Securities)
09066V103
 
(CUSIP Number)
December 31, 2009
 
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
þ Rule 13d-1(b)
o Rule 13d-1(c)
o Rule 13d-1(d)
 
*   The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 


 

                     
CUSIP No.
 
09066V103 
13G Page  
  of   
10 

 

           
1   NAME OF REPORTING PERSONS / I.R.S. IDENTIFICATION
NO. OF ABOVE PERSONS (ENTITIES ONLY)

CLOUGH CAPITAL PARTNERS L.P.
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  DELAWARE
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,456,296 (see Item 4)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,456,296 (see Item 4)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,456,296 (see Item 4)
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  7.92% (see Item 4)
     
12   TYPE OF REPORTING PERSON
   
  IA – Investment Adviser


 

                     
CUSIP No.
 
09066V103 
13G Page
  of   
10 

 

           
1   NAME OF REPORTING PERSONS / I.R.S. IDENTIFICATION
NO. OF ABOVE PERSONS (ENTITIES ONLY)

CLOUGH CAPITAL PARTNERS LLC
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  DELAWARE
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,456,296 (see Item 4)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,456,296 (see Item 4)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,456,296 (see Item 4)
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  7.92% (see Item 4)
     
12   TYPE OF REPORTING PERSON
   
  HC – Parent Holding Company/Control Person


 

                     
CUSIP No.
 
09066V103 
13G Page  
  of   
10 

 

           
1   NAME OF REPORTING PERSONS / I.R.S. IDENTIFICATION
NO. OF ABOVE PERSONS (ENTITIES ONLY)

CHARLES I. CLOUGH, JR.
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  UNITED STATES
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,456,296 (see Item 4)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,456,296 (see Item 4)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,456,296 (see Item 4)
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  7.92% (see Item 4)
     
12   TYPE OF REPORTING PERSON
   
  HC – Parent Holding Company/Control Person


 

                     
CUSIP No.
 
09066V103 
13G Page  
  of   
10 

 

           
1   NAME OF REPORTING PERSONS / I.R.S. IDENTIFICATION
NO. OF ABOVE PERSONS (ENTITIES ONLY)

JAMES E. CANTY
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  UNITED STATES
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,456,296 (see Item 4)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,456,296 (see Item 4)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,456,296 (see Item 4)
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  7.92% (see Item 4)
     
12   TYPE OF REPORTING PERSON
   
  HC – Parent Holding Company/Control Person


 

                     
CUSIP No.
 
09066V103 
13G Page  
  of   
10 

 

           
1   NAME OF REPORTING PERSONS / I.R.S. IDENTIFICATION
NO. OF ABOVE PERSONS (ENTITIES ONLY)

ERIC A. BROCK
     
2   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

  (a)   o
  (b)   o
     
3   SEC USE ONLY
   
   
     
4   CITIZENSHIP OR PLACE OF ORGANIZATION
   
  UNITED STATES
       
  5   SOLE VOTING POWER
     
NUMBER OF   0
       
SHARES 6   SHARED VOTING POWER
BENEFICIALLY    
OWNED BY   1,456,296 (see Item 4)
       
EACH 7   SOLE DISPOSITIVE POWER
REPORTING    
PERSON   0
       
WITH: 8   SHARED DISPOSITIVE POWER
     
    1,456,296 (see Item 4)
     
9   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
   
  1,456,296 (see Item 4)
     
10   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
   
  o
     
11   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
   
  7.92% (see Item 4)
     
12   TYPE OF REPORTING PERSON
   
  HC – Parent Holding Company/Control Person


 

CUSIP No.  09066V103 13G Page 7 of 10
ITEM 1.
  (a)   Name of Issuer: BioSphere Medical, Inc.
 
  (b)   Address of Issuer’s Principal Executive Offices:
 
    1050 Hingham St., Rockland, Massachusetts 02370
ITEM 2.
  (a)   and (c) Name and Domicile/Citizenship of Persons Filing:
 
    (i) Clough Capital Partners L.P., a Delaware limited partnership.
 
    (ii) Clough Capital Partners LLC, a Delaware limited liability company.
 
    (iii) Charles I. Clough, Jr., a United States citizen.
 
    (iv) James E. Canty, a United States citizen.
 
    (v) Eric A. Brock, a United States citizen.
  (b)   Each of the Reporting Persons has a business address of:
 
      One Post Office Square, 40th Floor, Boston, MA 02109
 
  (d)   Title of Class of Securities: Common Stock, par value $0.01 per share.
 
  (e)   CUSIP Number: 09066V103
ITEM 3.    IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A:
  (a)   o Broker or Dealer registered under Section 15 of the Act
 
  (b)   o Bank as defined in section 3(a)(6) of the Act
 
  (c)   o Insurance Company as defined in section 3(a)(19) of the Act
 
  (d)   o Investment Company registered under section 8 of the Investment Company Act of 1940
 
  (e)   þ Investment Adviser registered under section 203 of the Investment Advisers Act or under the laws of any State
 
  (f)   o Employee Benefit Plan, Pension fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Section 240.13d-1(b)(1)(ii)(F)
 
  (g)   þ A Parent Holding Company or control person, in accordance with Section 240.13d-1(b)(ii)(G) (Note: See Item 7)
 
  (h)   o A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act
 
  (i)   o A Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940
 
  (j)   o Group, in accordance with Section 240.13d-1(b)(1)(ii)(J)

 


 

CUSIP No.  09066V103   Page 8 of 10
ITEM 4. OWNERSHIP
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.
  (a)   Amount Beneficially Owned: 1,456,296 *
 
  (b)   Percent of Class: 7.92%*
 
  (c)   Number of shares as to which such person has:
  (i)   sole power to vote or to direct the vote: 0
 
  (ii)   shared power to vote or to direct the vote: 1,456,296 *
 
  (iii)   sole power to dispose or to direct the disposition of: 0
 
  (iv)   shared power to dispose or to direct the disposition of: 1,456,296 *
 
*   The shares reported above include shares beneficially owned by investment companies, pooled investment vehicles and other accounts for which Clough Capital Partners L.P. serves as investment adviser. Such shares may be deemed beneficially owned by (a) Clough Capital Partners L.P., (b) Clough Capital Partners LLC, the general partner of Clough Capital Partners L.P., and (c) Messrs. Clough, Canty and Brock, the managing members of Clough Capital Partners LLC. Each such reporting person disclaims beneficial ownership of such shares except to the extent of its respective pecuniary interest therein.
The share holding and percent of class data set forth above is reported as of the date of the filing of this statement on Schedule 13G.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
     If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following o.
ITEM 6.   OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
     Not Applicable.
ITEM 7.   IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
     See Exhibit 1.

 


 

CUSIP No. 09066V103 13G Page 9 of 10
ITEM 8.   IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
     Not Applicable.
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
     Not Applicable.
ITEM 10. CERTIFICATION
     By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 


 

CUSIP No. 09066V103 13G Page 10 of 10
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I hereby certify that the information set forth in this statement is true, complete and correct.
Date: February 9, 2010
           
  CLOUGH CAPITAL PARTNERS L.P.
 
 
     
     
 
     
        
  By  Clough Capital Partners LLC,   
       its general partner   
           
  By:   /s/ James E. Canty    
      James E. Canty,   
      a managing member   
 
         
  CLOUGH CAPITAL PARTNERS LLC
 
 
  By:  /s/ James E. Canty     
    James E. Canty,   
    a managing member   
 
  /s/ Charles I. Clough, Jr.    
  Charles I. Clough, Jr., individually   
       
  /s/ James E. Canty    
  James E. Canty, individually   
       
  /s/ Eric A. Brock    
  Eric A. Brock, individually   
       

 


 

         
Exhibit 1
     This statement on Schedule 13G (and any amendments hereto) is filed by (a) Clough Capital Partners L.P., (b) Clough Capital Partners LLC, the general partner of Clough Capital Partners L.P., and (c) each of Charles I. Clough, Jr., James E. Canty and Eric A. Brock, the managing members of Clough Capital Partners LLC.

 


 

Exhibit 2
JOINT FILING AGREEMENT
     This Joint Filing Agreement, dated as of February 9, 2010, is by and among Clough Capital Partners L.P., a Delaware limited partnership, Clough Capital Partners LLC, a Delaware limited liability company, Charles I. Clough, Jr., James E. Canty and Eric A. Brock (the foregoing are collectively referred to herein as the “Clough Capital Filers”).
     Each of the Clough Capital Filers may be required to file with the United States Securities and Exchange Commission a statement on Schedule 13G (and amendments thereto) with respect to shares of Common Stock, par value $0.01 per share, of BioSphere Medical, Inc., a Delaware corporation, beneficially owned by them from time to time.
     Pursuant to and in accordance with Rule 13(d)(1)(k) promulgated under the Securities Exchange Act of 1934, as amended, the Clough Capital Filers hereby agree to file a single statement on Schedule 13G (and any amendments thereto) on behalf of each of the Clough Capital Filers, and hereby further agree to file this Joint Filing Agreement as an exhibit to such statement, as required by such rule.
     This Joint Filing Agreement may be terminated by any of the Clough Capital Filers upon written notice to the other Clough Capital Filers.
     Executed and delivered as of the date first above written.
       
CLOUGH CAPITAL PARTNERS L.P.
   
 
 
   
By  Clough Capital Partners LLC,
  /s/ Charles I. Clough, Jr.
 
 
   
 
its general partner
  Charles I. Clough, Jr., individually
 
 
   
 By:
/s/ James E. Canty
  /s/ James E. Canty
 
 
   
 
James E. Canty, a managing member
  James E. Canty, individually
 
 
   
 
 
  /s/ Eric A. Brock
 
 
   
CLOUGH CAPITAL PARTNERS LLC
  Eric A. Brock, individually
 
 
   
By:  
/s/ James E. Canty
   
 
 
   
 
James E. Canty, a managing member
   

 

-----END PRIVACY-ENHANCED MESSAGE-----